Cyclic nucleotide phosphodiesterases
US5932423A · kind A · utility
9Cited by
1References
11Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Nov 19, 1997 |
| Grant date | Aug 3, 1999 |
| Priority date | — |
| Expiry date | Nov 19, 2017 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K38/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The invention provides human cyclic nucleotide phosphodiesterases (PDE8) and polynucleotides which identify and encode PDE8. The invention also provides expression vectors, host cells, antibodies, agonists, and antagonists. The invention also provides methods for treating or preventing disorders associated with expression of PDE8.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.